An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Anika Therapeutics, Inc. (NASDAQ: ANIK) will release its first quarter 2024 financial results on May 8, 2024, followed by an investor conference call to discuss business highlights.
Anika Therapeutics, Inc. (NASDAQ: ANIK) pubblicherà i risultati finanziari del primo trimestre del 2024 l'8 maggio 2024, seguiti da una conferenza telefonica con gli investitori per discutere dei punti salienti dell'attività.
Anika Therapeutics, Inc. (NASDAQ: ANIK) dará a conocer los resultados financieros del primer trimestre de 2024 el 8 de mayo de 2024, seguido por una conferencia telefónica con inversores para discutir los aspectos destacados del negocio.
Anika Therapeutics, Inc. (NASDAQ: ANIK)는 2024년 5월 8일에 2024년 첫 분기 재무 결과를 발표한 후 사업 하이라이트에 대해 논의하기 위한 투자자 컨퍼런스 콜을 개최할 예정입니다.
Anika Therapeutics, Inc. (NASDAQ: ANIK) publiera ses résultats financiers pour le premier trimestre 2024 le 8 mai 2024, suivis d'une conférence téléphonique avec les investisseurs pour discuter des points forts de l'entreprise.
Anika Therapeutics, Inc. (NASDAQ: ANIK) wird am 8. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 veröffentlichen, gefolgt von einer Telefonkonferenz mit Investoren, um Geschäftshighlights zu besprechen.
Positive
None.
Negative
None.
BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2024 financial results after the close of the market on Wednesday, May 8, 2024 and hold its investor conference call on the same day, at 5:30 p.m. ET to discuss its financial results and business highlights.
The conference call can be accessed by dialing 1-888-886-7786 (toll-free domestic) or 1-416-764-8658 (international) and providing the conference ID number 1665626. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries: Anika Therapeutics, Inc. Mark Namaroff, 781-457-9287 Vice President, Investor Relations, ESG and Corporate Communications investorrelations@anika.com
FAQ
When will Anika Therapeutics release its first quarter 2024 financial results?
Anika Therapeutics will release its first quarter 2024 financial results on May 8, 2024.
What time is the investor conference call scheduled for?
The investor conference call is scheduled for 5:30 p.m. ET on May 8, 2024.
How can I access the conference call?
You can access the conference call by dialing 1-888-886-7786 (toll-free domestic) or 1-416-764-8658 (international) and providing the conference ID number 1665626.
Where can I find the live audio webcast of the conference call?
The live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com.
Will the conference call be archived for later access?
Yes, the conference call will be archived and accessible on the Anika website shortly after its conclusion.
who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an
